BioCentury | Sep 13, 2010
Strategy
Back to School 2010: Regulatory innovation
...testing novel agents in first-line settings for diseases that can be treated with existing therapies. Adaptive screening...
...Figure: I-SPY 2 trial design I-SPY 2 is an example of a parallel-throughput Phase II adaptive screening...
...Figure: I-SPY 2 trial design I-SPY 2 is an example of a parallel-throughput Phase II adaptive screening...
